CS-003, a novel triple neurokinin receptor antagonist, inhibits symptoms of respiratory diseases models in guinea pigs

H. Tsuchida, S. Takahashi, T. Kuraya, K. Morimoto, M. Yamashita (Tokyo, Japan)

Source: Annual Congress 2006 - Recent advances in the treatment of asthma and allergic rhinitis
Session: Recent advances in the treatment of asthma and allergic rhinitis
Session type: Thematic Poster Session
Number: 3854
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Tsuchida, S. Takahashi, T. Kuraya, K. Morimoto, M. Yamashita (Tokyo, Japan). CS-003, a novel triple neurokinin receptor antagonist, inhibits symptoms of respiratory diseases models in guinea pigs. Eur Respir J 2006; 28: Suppl. 50, 3854

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The triple neurokinin receptor antagonist CS-003 inhibits neurokinin A (NKA)-induced bronchoconstriction in patients with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 415s
Year: 2003

Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 219s
Year: 2004

The cannabinoid receptor agonist, WIN 55,212-2, inhibits antigen-induced plasma extravasation in guinea pig airways
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


A novel dual-agonist challenge model in guinea pigs for assessment of individual and combined muscarinics antagonists and b2 adrenoceptor agonists bronchodilator efficacy
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011

Alpha-1L, but not alpha-1H, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo
Source: Eur Respir J 2001; 18: Suppl. 33, 104s
Year: 2001

Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients
Source: Eur Respir J 2004; 23: 76-81
Year: 2004



Novel triple neurokinin receptors antagonist CS-003 strongly inhibits neurokinin related responses
Source: Eur Respir J 2006; 28: Suppl. 50, 115s
Year: 2006

A novel TRPA1 antagonist inhibits ovalbumin-induced bronchoconstriction in guinea pig models
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019

Efficacy of UR-63325, a new H4 receptor antagonist, in two rodent asthma models
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea
Source: Eur Respir J 2003; 21: 3-10
Year: 2003



Cystenyl-leukotriene receptor antagonist (LRA) inhibits respiratory burst of human neutrophils
Source: Eur Respir J 2003; 22: Suppl. 45, 316s
Year: 2003

Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008

Mas receptor antagonist inhibits the pro-resolutive effects of Angiotensin-(1-7) in an experimental model of asthma.
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Discovery of competitive thromboxane receptor (TP) antagonism by diclofenac in guinea pig airway and vascular tissues
Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology
Year: 2007


Pharmacological activities of R-113281, a triple NK1 /NK2 /NK3 neurokinin receptor antagonist
Source: Eur Respir J 2001; 18: Suppl. 33, 264s
Year: 2001

Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4-induced contractions of isolated human bronchi
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005

An orally available, highly selective 5-hydroxytryptamine 2B (5-HT2B) receptor antagonist ameliorating pulmonary and dermal fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019


Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



In vitro pharmacological profile of CHF 5407, a potent, long-acting and selective muscarinic M3 receptor antagonist
Source: Eur Respir J 2007; 30: Suppl. 51, 25s
Year: 2007